Table 1.

Results of biochemical analysis performed on rat serum subjected to different treatments at 34th weeks post injection of DENA.

GP	Total protein (g/dL)	Albumin (g/dL)	ALT (U/L)	AST (U/L)	Urea (mg/dL)	Creatinine (mg/dL)
I	9.33 ± 2.25a,b	4.33 ± 0.24b	23.66 ± 1.33	23.33 ± 4.33a	37.79 ± 4.96b,c	0.90 ± 0.09b,c
II	11.56 ± 1.96b	4.4 ± 0.10b	23.66 ± 1.33	37.66 ± 1.66a	27.46 ± 2.17a,b	0.65 ± 0.03a
III	6.43 ± 1.35a	4.06 ± 3.33b	19.66 ± 2.6	23.66 ± 6.22a	40.13 ± 3.2b,c	0.8 ± 0.05a,b,c
IV	12.48 ± 1.24b	4.30 ± 1b	29 ± 0	38 ± 7a	37.39 ± 6.3b,c	0.69 ± 0.08a
V	10.53 ± 1.55a,b	4.33 ± 3.33b	22.33 ± 1.33	30.33 ± 1.27a	24.5 ± 1.27a	0.77 ± 0.01a,b
VI	7.8 ± 0.40a,b	4.36 ± 0.18b	21 ± 0	48 ± 9.6a,b	37.03 ± 3b,c	0.81 ± 0.04a,b,c
VII	12.26 ± 0.17b	3.13 ± 0.23a	26.33 ± 1.33	31.33 ± 2.6a	47.13 ± 3.94 c	0.92 ± 0.02b,c
VIII	9.93 ± 0.88a,b	4.3 ± 0.15b	22.33 ± 3.5	65 ± 13.85b	35.03 ± 2.5a,b,c	0.98 ± 0.07c

All data presented as mean value (n = 3) ± standard error. Values bearing different superscripts (a,b,c) are significant at p < 0.05. Group I is a control negative group. Group II was treated with camel milk. Group III treated with cisplatin. Group IV treated with camel milk and cisplatin. Group V injected with DENA. Group VI injected with DENA and treated with camel milk. Group VII injected with DENA and treated with cisplatin. Group VIII injected with DENA and treated with cisplatin and camel milk.